Valuation: Elekta AB (publ)

Market Cap 18.74B 1.93B 1.69B 1.56B 1.45B 2.74B 182B 2.8B 7.23B 89.84B 7.23B 7.08B 312B P/E 2026
-39.2x
P/E 2027 * 13.2x
Enterprise Value 22.76B 2.34B 2.05B 1.89B 1.77B 3.32B 221B 3.4B 8.79B 109B 8.79B 8.59B 379B EV / Sales 2026
1.41x
EV / Sales 2027 * 1.28x
Free-Float
94.03%
Yield 2026
4.51%
Yield 2027 * 5.15%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 1.93B
-1.02%+6.63%+23.43%-4.08% 188B
-1.07%-0.41%-26.11%+17.43% 144B
-0.91%+6.55%-3.47%-20.55% 136B
-2.41%-6.74%-60.41%-21.38% 64.63B
-0.78%+4.13%+15.77%-4.01% 52.5B
+0.78%-0.78%-27.22%-33.96% 43.4B
-0.88%+3.72%+11.33%+9.26% 37.52B
-0.23%+2.61%+5.01%+37.51% 36.22B
-2.14%-0.38%-14.30%-21.86% 29.59B
Average -0.76%+4.47%-8.44%-4.63% 81.36B
Weighted average by Cap. -1.00%+5.68%-5.32%-4.20%

Financials

2026 2027 *
Net sales 16.97B 1.74B 1.53B 1.41B 1.32B 2.48B 165B 2.53B 6.55B 81.36B 6.55B 6.41B 282B 17.38B 1.79B 1.56B 1.44B 1.35B 2.54B 169B 2.6B 6.71B 83.36B 6.71B 6.56B 289B
Net income 850M 87.34M 76.48M 70.6M 65.93M 124M 8.26B 127M 328M 4.07B 328M 321M 14.14B 1.43B 147M 128M 119M 111M 208M 13.86B 213M 551M 6.84B 551M 538M 23.74B
Net Debt 4.02B 413M 362M 334M 312M 587M 39.07B 601M 1.55B 19.28B 1.55B 1.52B 66.93B 3.48B 358M 313M 289M 270M 509M 33.84B 520M 1.34B 16.7B 1.34B 1.31B 57.97B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-